Certain early-stage lung cancer patients who take the drug Tagrisso (osimertinib) after surgery may dramatically boost their survival odds, new study results suggest.
Read more: https://www.everydayhealth.com/lung-cancer/lung-cancer-pill-cuts-death-risk-by-half-in-new-study/
